PD-1 inhibitor based immunotherapy: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 2 1

Condition	Trials
Chemoradiotherapy	1
Colorectal cancer	1
Immunotherapy	1
Rectal Adenocarcinoma	1
Rectal Cancer	1
Rectal Cancer Patients	1
Rectal Cancer, Radiotherapy	1
Targeted Therapy	1
Total Neoadjuvant Therapy	1
Total Neoadjuvant Treatment	1

SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC
NCT07198165 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

1 recruiting trial across 10 conditions.

No. For the full record, search ClinicalTrials.gov.